Evaluation and treatment of Chagas disease in the United States: a systematic review

C Bern, SP Montgomery, BL Herwaldt, A Rassi… - Jama, 2007 - jamanetwork.com
ContextBecause of population migration from endemic areas and newly instituted blood
bank screening, US clinicians are likely to see an increasing number of patients with …

Pathogen diversity, immunity, and the fate of infections: lessons learned from Trypanosoma cruzi human–host interactions

LMD Magalhães, KJ Gollob, B Zingales… - The Lancet …, 2022 - thelancet.com
The complexity of host–pathogen interactions often leads to distinct clinical outcomes upon
infection with different pathogen strains. In this Review, we explore the interactions between …

Localized cardiac small molecule trajectories and persistent chemical sequelae in experimental Chagas disease

Z Liu, R Ulrich vonBargen, AL Kendricks… - Nature …, 2023 - nature.com
Post-infectious conditions present major health burdens but remain poorly understood. In
Chagas disease (CD), caused by Trypanosoma cruzi parasites, antiparasitic agents that …

The unsolved jigsaw puzzle of the immune response in Chagas disease

GR Acevedo, MC Girard, KA Gómez - Frontiers in immunology, 2018 - frontiersin.org
Trypanosoma cruzi interacts with the different arms of the innate and adaptive host's immune
response in a very complex and flowery manner. The history of host-parasite co-evolution …

Immunoregulatory networks in human C hagas disease

WO Dutra, CAS Menezes, LMD Magalhães… - Parasite …, 2014 - Wiley Online Library
Chagas disease, caused by the infection with T rypanosoma cruzi, is endemic in all L atin A
merica. Due to the increase in population migration, C hagas disease has spread worldwide …

CD8+ T-Cell Responses to Trypanosoma cruzi Are Highly Focused on Strain-Variant trans-Sialidase Epitopes

DL Martin, DB Weatherly, SA Laucella… - PLoS …, 2006 - journals.plos.org
CD8+ T cells are crucial for control of a number of medically important protozoan parasites,
including Trypanosoma cruzi, the agent of human Chagas disease. Yet, in contrast to the …

[HTML][HTML] Congenital Chagas disease as an ecological model of interactions between Trypanosoma cruzi parasites, pregnant women, placenta and fetuses

Y Carlier, C Truyens - Acta Tropica, 2015 - Elsevier
The aim of this paper is to discuss the main ecological interactions between the parasite
Trypanosoma cruzi and its hosts, the mother and the fetus, leading to the transmission and …

Drug-induced cure drives conversion to a stable and protective CD8+ T central memory response in chronic Chagas disease

JM Bustamante, LM Bixby, RL Tarleton - Nature medicine, 2008 - nature.com
In this study, we document the development of stable, antigen-independent CD8+ T cell
memory after drug-induced cure of a chronic infection. By establishing a system for drug …

Cardiomyocyte infection by Trypanosoma cruzi promotes innate immune response and glycolysis activation

G Venturini, JM Alvim, K Padilha, CN Toepfer… - Frontiers in cellular …, 2023 - frontiersin.org
Introduction Chagas cardiomyopathy, a disease caused by Trypanosoma cruzi (T. cruzi)
infection, is a major contributor to heart failure in Latin America. There are significant gaps in …

CD8+ T cells in Trypanosoma cruzi infection

AM Padilla, JM Bustamante, RL Tarleton - Current opinion in immunology, 2009 - Elsevier
CD8+ T cells have emerged as crucial players in the control of a number of protozoan
pathogens, including Trypanosoma cruzi, the agent of human Chagas disease. The recent …